Table 1. Patient details.
| Patient ID/ age/sex | Aneurysm location | Symptoms | Day of PET (SAH=0) | rCBF (PCT) left/right (mL/100 g/min) | FMISO trapping in MD-ROI (close to) | Trapping within the vascular territory of the aneurysm | GOS (12 months) |
|---|---|---|---|---|---|---|---|
| 185/41/F | L MCA | Aphasia, centralis facialis paresis | 4 | 20.9/19.8 | + | + | 5 |
| 186/62/F | L MCA | R hemiparesis, aphasia, somnolent | 5 | − | + | + | 3 |
| 189/64/F | R MCA | Asymptomatic | 12 | 48.4/33.2 | − | − | 5 |
| 190/49/F | R MCA | L hemiparesis, aphasia | 7 | 28.4/22.6 | (+) | + | 4 |
| 192/63/F | L PCA | Aphasia | 8 | (198.2/144.9)a | − | − | 5 |
| 197/45/F | L MCA | Asymptomatic | 4 | – | − | − | 5 |
| 199/37/M | L MCA | Asymptomatic | 8 | 27.5/28.5 | − | − | 5 |
F, female; FMISO, fluoromisonidazole; GOS, Glasgow Outcome Scale; L, left; M, male; MCA, middle cerebral artery; MD-ROI, microdialysis-region of interest; PCT, perfusion-computed tomography; PET, positron emission tomography; R, right; rCBF, regional cerebral blood flow; ROI, region of interest; SAH, subarachnoidal hemorrhage.
Data are expressed as absolute numbers.
a
Unexplained extremely high rCBF values (rather a bug than a combination of cortical hyperemia and partial volume effects).